Immediate Impact

73 standout
Sub-graph 1 of 22

Citing Papers

Hypoxia-tropic delivery of nanozymes targeting transferrin receptor 1 for nasopharyngeal carcinoma radiotherapy sensitization
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
3 intermediate papers

Works of R. James Graydon being referenced

A phase I study of milademetan in combination with quizartinib in patients (pts) with newly diagnosed (ND) or relapsed/refractory (R/R) FLT3-ITD acute myeloid leukemia (AML).
2019
A Double-Blind, Randomized Trial on the Efficacy and Safety of Hyperbaric Oxygenation Therapy in the Preservation of Erectile Function after Radical Prostatectomy
2017

Author Peers

Author Last Decade Papers Cites
R. James Graydon 184 300 116 270 184 12 513
A. McCullough 224 326 133 186 244 15 637
Amr El-Meliegy 68 440 87 351 152 11 612
Carlos Ary Vargas Souto 95 348 114 322 214 24 594
Luigi Barbieri 78 519 123 283 270 20 607
Giulia Castagna 81 265 49 235 106 20 502
Daniel J. Moskovic 97 165 151 210 60 18 469
Brenda Johnston 56 309 72 330 216 11 565
William P. Fitch 96 370 122 272 268 14 564
Herbert M. User 216 291 133 102 188 14 516
S. Degli Innocenti 108 98 85 154 238 8 517

All Works

Loading papers...

Rankless by CCL
2026